Cas:7412-78-4 β-Endorphin (30-31) (human) manufacturer & supplier

Chemical Name:β-Endorphin (30-31) (human)

CAS.NO:7412-78-4

Synonyms:L-Glutamic acid, N-glycyl-;N-glycylglutamic acid;H2N-glycine-Acide glutamique-OH;EINECS 231-019-4;H-Gly-Glu-OH;Glycylglutamic acid;Gly-L-Glu-OH;L-Glutamic acid,N-glycyl;GLY-GLU;MFCD00008128;Glycyl-L-glutamic acid;L-Glutamic acid, glycyl-;N-glycyl-L-glutamic acid;Gly-Glu-OH

Molecular Formula:C₇H₁₂N₂O₅

Molecular Weight:204.181

HS Code:2924199090

Physical and Chemical Properties:

Melting point:155-158ºC (dec.)(lit.)

Boiling point:536.6±50.0 °C at 760 mmHg

Density:1.4±0.1 g/cm3

Index of Refraction:1.537

PSA:129.72000

Exact Mass:204.074615

LogP:-2.68

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:NONH for all modes of transpor

Packing Group:

Contact us for information like L-Glutamic acid, N-glycyl- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Gly-Glu-OH physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,MFCD00008128 Use and application,Gly-Glu-OH technical grade,usp/ep/jp grade.

Related News: The April halt followed the discovery that ingredients from AstraZeneca’s (AZN.L) COVID-19 vaccine, also being produced at the plant at the time, contaminated a batch of J&J’s vaccine. AstraZeneca’s shot is no longer being made there. β-Endorphin (30-31) (human) manufacturer In addition, the FDA approval ignored the recommendation of its outside advisors, who said Biogen did not provide enough evidence of clinical benefit. Three of the advisory panel’s members have resigned in protest since the FDA decision was announced on Monday. β-Endorphin (30-31) (human) supplier Active Pharmaceutical Ingredients (APIs): Pharmaceutical active ingredients, which are the basic substances that constitute the pharmacological effects of pharmaceuticals, and are prepared by chemical synthesis, plant extraction, or biotechnology. β-Endorphin (30-31) (human) vendor The April halt followed the discovery that ingredients from AstraZeneca’s (AZN.L) COVID-19 vaccine, also being produced at the plant at the time, contaminated a batch of J&J’s vaccine. AstraZeneca’s shot is no longer being made there. β-Endorphin (30-31) (human) factory The April halt followed the discovery that ingredients from AstraZeneca’s (AZN.L) COVID-19 vaccine, also being produced at the plant at the time, contaminated a batch of J&J’s vaccine. AstraZeneca’s shot is no longer being made there.